These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35752848)

  • 1. Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome.
    Rosenfeld E; Nanga RPR; Lucas A; Revell AY; Thomas A; Thomas NH; Roalf DR; Shinohara RT; Reddy R; Davis KA; De León DD
    Orphanet J Rare Dis; 2022 Jun; 17(1):248. PubMed ID: 35752848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.
    Raizen DM; Brooks-Kayal A; Steinkrauss L; Tennekoon GI; Stanley CA; Kelly A
    J Pediatr; 2005 Mar; 146(3):388-94. PubMed ID: 15756227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.
    Tran C; Konstantopoulou V; Mecjia M; Perlman K; Mercimek-Mahmutoglu S; Kronick JB
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):873-6. PubMed ID: 25781533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations.
    Kapoor RR; Flanagan SE; Fulton P; Chakrapani A; Chadefaux B; Ben-Omran T; Banerjee I; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2009 Nov; 161(5):731-5. PubMed ID: 19690084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution.
    Brandt A; Agarwal N; Giri D; Yung Z; Didi M; Senniappan S
    J Pediatr Endocrinol Metab; 2020 May; 33(5):675-679. PubMed ID: 32229669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism.
    Stanley CA
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S45-51. PubMed ID: 15050973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures and diagnostic difficulties in hyperinsulinism-hyperammonemia syndrome.
    Aka S; Alanay Y; Boodhansingh KE; Stanley CA; Semiz S
    Turk J Pediatr; 2016; 58(5):541-544. PubMed ID: 28621098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two unrelated Chinese patients with hyperinsulinism /hyperammonemia (HI/HA) syndrome due to mutations in glutamate dehydrogenase gene.
    Diao C; Chen S; Xiao X; Wang T; Sun X; Wang O; Song H; Zhang Y; Yu M; Zhang Q; Wang H
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):733-8. PubMed ID: 20857847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene.
    Corrêa-Giannella ML; Freire DS; Cavaleiro AM; Fortes MA; Giorgi RR; Pereira MA
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):485-9. PubMed ID: 23295286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase.
    MacMullen C; Fang J; Hsu BY; Kelly A; de Lonlay-Debeney P; Saudubray JM; Ganguly A; Smith TJ; Stanley CA;
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1782-7. PubMed ID: 11297618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome.
    Balasubramaniam S; Kapoor R; Yeow JH; Lim PG; Flanagan S; Ellard S; Hussain K
    J Pediatr Endocrinol Metab; 2011; 24(7-8):573-7. PubMed ID: 21932603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.
    Ninković D; Sarnavka V; Bašnec A; Ćuk M; Ramadža DP; Fumić K; Kušec V; Santer R; Barić I
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1083-8. PubMed ID: 27383869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA).
    Fang C; Ding X; Huang Y; Huang J; Zhao P; Hu J
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):385-8. PubMed ID: 26656609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hyperinsulinism/hyperammonemia syndrome.
    Palladino AA; Stanley CA
    Rev Endocr Metab Disord; 2010 Sep; 11(3):171-8. PubMed ID: 20936362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
    Roy K; Satapathy AK; Houhton JAL; Flanagan SE; Radha V; Mohan V; Sharma R; Jain V
    Indian J Pediatr; 2019 Nov; 86(11):1051-1053. PubMed ID: 31119523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
    De Los Santos-La Torre MA; Del Águila-Villar CM; Lu-de Lama LR; Nuñez-Almache O; Chávez-Tejada EM; Espinoza-Robles OA; Pinto-Ibárcena PM; Calagua-Quispe MR; Azabache-Tafur PM; Tucto-Manchego RM
    J Pediatr Endocrinol Metab; 2023 Feb; 36(2):207-211. PubMed ID: 36476334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
    Grimaldi M; Karaca M; Latini L; Brioudes E; Schalch T; Maechler P
    Hum Mol Genet; 2017 Sep; 26(18):3453-3465. PubMed ID: 28911206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.
    Bahi-Buisson N; Roze E; Dionisi C; Escande F; Valayannopoulos V; Feillet F; Heinrichs C; Chadefaux-Vekemans B; Dan B; de Lonlay P
    Dev Med Child Neurol; 2008 Dec; 50(12):945-9. PubMed ID: 19046187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators.
    Stanley CA; Fang J; Kutyna K; Hsu BY; Ming JE; Glaser B; Poncz M
    Diabetes; 2000 Apr; 49(4):667-73. PubMed ID: 10871207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase.
    Luczkowska K; Stekelenburg C; Sloan-Béna F; Ranza E; Gastaldi G; Schwitzgebel V; Maechler P
    Hum Genomics; 2020 Mar; 14(1):9. PubMed ID: 32143698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.